Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
AIDS and Behavior
Erschienen in: AIDS and Behavior 8/2012

01.11.2012 | Original Paper

Sensitivity and Specificity of a Visual Depression Screening Instrument Among HIV-Positive Individuals in Uganda, an Area with Low Literacy

verfasst von: Dickens Akena, John Joska, Seggane Musisi, Dan J. Stein

Erschienen in: AIDS and Behavior | Ausgabe 8/2012

Einloggen, um Zugang zu erhalten

Abstract

Given the high prevalence of depression in PHC, the use of depression screening instruments has often been recommended. The aim of this study was to construct and validate a visual depression screening instrument in a setting of low literacy and a high burden of HIV/AIDS. We engaged the help of a fine artist to draw pictures depicting DSM-IV-TR criteria for a depressive episode. We then validated this instrument named the Akena’s visual depression inventory (AVIDI), in 92 persons living with HIV/AIDS in Uganda. The performance of the AVIDI in those with high and low education levels was determined. The area under curve (AUC) score of the AVIDI was 0.82. There was no difference between the AUC scores in persons with lower versus higher education levels. The AVIDI demonstrated a good psychometric property and can therefore be used to screen for depression in settings with higher rates of illiteracy.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Organization WH. HIV/AIDS and mental health: WHO;2008.
2.
Ministry of Health of Uganda. Preliminary Results of the Uganda HIV/AIDS Sero-Behavioural Survey (UHSBS). Kampala: Ministry of Health; 2005.
3.
Olatunji BO, Mimiaga MJ, O’Cleirigh C, Safren SA. Review of treatment studies of depression in HIV. International AIDS Society-USA Topics in HIV Medicine, Review-Depression and HIV. 2006;14(3):112–24.
4.
Jeffrey A, Roberts JE. Meta-analysis of the relationship between HIV infection and risk for depressive disorders. Am J Psychiatry. 2001;158:725–30.CrossRef
5.
Murray CJ, Lopez AD. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet. 1997;349:1436–42.PubMedCrossRef
6.
Prince M, Patel V, Saxena S, et al. Global Mental Health 1 No health without mental health. Lancet. 2007;370:859–77.PubMedCrossRef
7.
Patel V, Simon G, Chowdhary N, Kaaya S, Araya R. Packages of care for depression in low- and middle-income countries. PLoS Med;2009:6(10):e1000159.
8.
Patel V. Mental health in low- and middle-income countries. Br Med Bull. 2007;81–82:81–96.PubMedCrossRef
9.
Patel V, Weiss HA, Chowdhary N, et al. Effectiveness of an intervention led by lay health counsellors for depressive and anxiety disorders in primary care in Goa, India (MANAS): a cluster randomised controlled trial. Lancet. 2010;376:2086–95.PubMedCrossRef
10.
Faydi E, Funk M, Kleintjes S, et al. An assessment of mental health policy in Ghana, South Africa, Uganda and Zambia. Health Res Policy Syst. 2011;9:17. Biomed central.PubMedCrossRef
11.
NICE. Depression: management of depression in primary and secondary care. National Institute of Clinical Excellence: London;2004.
12.
USPSTF. Screening for depression, recommendations and rationale: US preventive services Task Force 1996.
13.
Gilbodyl S, Sheldon T, House A. Screening and case-finding instruments for depression: a meta-analysis. CMAJ. 2008;178(8):997–1003.CrossRef
14.
Spitzer R, Kroenke K, Williams J. Validation and utility of a self-report version of PRIME-MD: the PHQ Primary Care Study. J Am Med Assoc. 1999;282:1737–44.CrossRef
15.
Beck AI, Steer RA, Carbin MC. Psychometric properties of the beck depression inventory: twenty-five years of evaluation. Clin Psychol Rev. 1988;8:77–100.CrossRef
16.
Radloff LS. Center for epidemiologic studies depression scale (CESD). In: Center for Epidemiologic Studies NIMH, Publisher, West Publishing Company, ed. 1977.
17.
Patel V, Pereira J, Coutinho L, Fernandes R, Fernandes J, Mann A. Poverty, psychological disorder and disability in primary care attenders in Goa, India. Br J Psychiatry. 1998;171:533–6.CrossRef
18.
19.
Puertas G, Patel V, Marshall T. Are visual measures of mood superior to questionnaire measures in non-Western settings? Soc Psychiatry Psychiatr Epidemiol. 2004;39:662–6.PubMedCrossRef
20.
Aitken RCB. Measurement of feelings using visual analogue scales. Proc R Soc Med. 1969;62:989–93.PubMed
21.
Ickovics JR, Hamburger ME, Vlahov D. Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV Epidemiology Research Study. JAMA. 2001;285:1466–74.PubMedCrossRef
22.
Sherbourne CD, Hays RD, Fleishman JA, et al. Impact of psychiatric conditions on health-related quality of life in persons with HIV infection. Am J Psychiatry. 2000;157:248–54.PubMedCrossRef
23.
Ammassari A, Antinori A, Aloisi MS, et al. Depressive symptoms, neurocognitive impairment, and adherence to highly active antiretroviral therapy among HIV-infected persons. Psychosomatics. 2004;45:394–402.PubMedCrossRef
24.
Horberg MA, Silverberg MJ, Hurley LB, et al. Effects of depression and selective serotonin reuptake inhibitor use on adherence to highly active antiretroviral therapy and on clinical outcomes in HIV-infected patients. J Acquir Immune Defic Syndr. 2008;47:384–90.PubMedCrossRef
25.
Treisman G, Angelino A. Interrelation between psychiatric disorders and the prevention and treatment of HIV infection. Clin Infect Dis. 2007;45:S313–7.PubMedCrossRef
26.
Cruess DG, Douglas SD, Petitto JM, et al. Association of resolution of major depression with increased natural killer cell activity among HIV-seropositive women. Am J Psychiatry. 2005;162:2125–30.PubMedCrossRef
27.
Evans DL, Ten Have TR, Douglas SD, et al. Association of depression with viral load, CD8 T lymphocytes, and natural killer cells in women with HIV infection. Am J Psychiatry. 2002;159:1752–9.PubMedCrossRef
28.
Rabkin JG, Wagner GJ, Rabkin R. Fluoxetine treatment for depression in patients with HIV and AIDS: a randomized, placebo-controlled trial. Am J Psychiatry. 1999;156:101–7.PubMed
29.
Bass J, Neugebauer R, Clougherty KF, et al. Group interpersonal psychotherapy for depression in rural Uganda: 6-month outcomes: randomised controlled trial. Br J Psychiatry. 2006;188:567–73.PubMedCrossRef
30.
Cuijpers P, van Straten A, van Schaik A, Andersson G. Psychological treatment of depression in primary care: a meta-analysis. Br J Gen Pract. 2009;59:e51–60.PubMedCrossRef
31.
Sheehan DV, Lecrubier Y, Harnett-Sheehan K. The Mini International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview. J Clin Psychiatry. 1998;59(suppl 20):22–33.PubMed
32.
Okello ES, Ekblad S. Lay concepts of depression among the Baganda of Uganda: a pilot study. Transcult Psychiatry. 2006;43(2):287–313.PubMedCrossRef
33.
Nakasujja N, Skolasky RL, Musisi S, et al. Depression symptoms and cognitive function among individuals with advanced HIV infection initiating HAART in Uganda. BMC Psychiatry. 2010;10:44.PubMedCrossRef
34.
Spies G, Kader A, Kidd M, et al. Validity of the K-10 in detecting DSM-IV-defined depression and anxiety disorders among HIV-infected individuals. AIDS Care. 2009;21(9):1163–8.PubMedCrossRef
35.
Baggaley RF, Ganaba R, Filippi V, et al. Short communication: detecting depression after pregnancy the validity of the K10 and K6 in Burkina Faso. Trop Med Int Health. 2007;12(10):1225–9.PubMedCrossRef
36.
STATA Inventor; 4905 Lakeway Drive College Station. Texas 77845 USA 800-STATA-PC. assignee. STATA, Statistics/Data Analysis;2011.
37.
Fischer JE, Bachmann LM, Jaeschke R. A readers’ guide to the interpretation of diagnostic test properties. Clinical example of sepsis. Intensive Care Med. 2003;29(7):1043–51.PubMedCrossRef
38.
Swets JA. Measuring the accuracy of diagnostic systems. Science. 1998;240(4857):1285–93.CrossRef
39.
Mogga S, Prince M, Alem A, et al. Outcome of major depression in Ethiopia: population-based study. Br J Psychiatry. 2006;189:241–6.PubMedCrossRef
40.
Monahan PO, Shacham E, Reece M, et al. Validity/reliability of PHQ-9 and PHQ-2 depression scales among adults living with HIV/AIDS in western Kenya. J Gen Intern Med. 2008;24(2):189–97.PubMedCrossRef
41.
Kertzman S, Aladjem Z, Milo R, et al. The utility of the Visual Analogue Scale for the assessment of depressive mood in cognitively impaired patients. Int J Geriatr Psychiatry. 2004;19:789–96.PubMedCrossRef
42.
Price CIM, Urless RH, Rodgers H. Can stroke patients use visual analogue scales? Stroke. 1999;30:1357–61.PubMedCrossRef
43.
Berg A, Lönnqvist J, Palomäki H, Kaste M. Assessment of depression after stroke: a comparison of different screening instruments. Stroke. 2009;40:523–9.PubMedCrossRef
44.
Myer L, Smit J, Roux LL, Parker S, Stein DJ, Seedat S. Common mental disorders among HIV-infected individuals in South Africa: prevalence, predictors, and validation of brief psychiatric rating scales. AIDS Patient Care STDs. 2008;22(2):147–58.PubMedCrossRef
45.
Omoro SAO, Fann JR, Weymuller EA, Macharia IM, Yueh B. Swahili translation and validation of the Patient Health Questionnaire-9 depression scale in the Kenyan head and neck cancer patient population. Int J Psychiatry Med. 2006;36(3):367–81. PMID 17236703.PubMedCrossRef
46.
Adewuya AO, Ola BA, Afolabi OO. Validity of the patient health questionnaire (PHQ-9) as a screening tool for depression amongst Nigerian university students. J Affect Disord. 2006;96(2006):89–93.PubMedCrossRef
Metadaten
Titel
Sensitivity and Specificity of a Visual Depression Screening Instrument Among HIV-Positive Individuals in Uganda, an Area with Low Literacy
verfasst von
Dickens Akena
John Joska
Seggane Musisi
Dan J. Stein
Publikationsdatum
01.11.2012
Verlag
Springer US
Erschienen in
AIDS and Behavior / Ausgabe 8/2012
Print ISSN: 1090-7165
Elektronische ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-012-0267-1

Weitere Artikel der Ausgabe 8/2012

AIDS and Behavior 8/2012 Zur Ausgabe

Original Paper

Exploring the Psychological Impact of HIV: Health Comparisons of Older Australian HIV-Positive and HIV-Negative Gay Men

Original Paper

Labor Force Participation and Health-Related Quality of Life in HIV-Positive Men Who Have Sex with Men: The Multicenter AIDS Cohort Study

Original Paper

Aging, Prospective Memory, and Health-Related Quality of Life in HIV Infection

Original Paper

Predicting Depression in Mothers With and Without HIV: The Role of Social Support and Family Dynamics

Original Paper

Recent Trauma is Associated with Antiretroviral Failure and HIV Transmission Risk Behavior Among HIV-Positive Women and Female-Identified Transgenders

Original Paper

Development of a New Instrument for the Assessment of Psychological Predictors of Well-being and Quality of Life in People with HIV or AIDS

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise